Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nersting

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|June 11, 2020
Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemiaRikke Hebo Larsen, Lisa Lyngsie Hjalgrim, Kathrine Grell, et al.
The Lancet. Oncology|March 5, 2017
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trialStine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, et al.
Journal of Crohn'S & Colitis|June 20, 2018
Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel DiseaseAnne Grosen, Jacob Nersting, Mona Bungum, et al.
Pediatric Blood & Cancer|July 23, 2016
Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?Kjeld Schmiegelow, Jacob Nersting, Stine Nygaard Nielsen, et al.
BMC Health Services Research|December 5, 2020
Interprofessional versus monoprofessional case-based learning in childhood cancer and the effect on healthcare professionals' knowledge and attitudes: study protocol for a randomised trialMartha Krogh Topperzer, Marianne Hoffmann, Hanne Bækgaard Larsen, et al.
Pediatric Blood & Cancer|May 10, 2018
Testing physical function in children undergoing intense cancer treatment-a RESPECT feasibility studyMartin K F Nielsen, Jesper F Christensen, Thomas L Frandsen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Blood|February 20, 2009
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 studyKjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, et al.
Pediatric Hematology and Oncology|November 18, 2020
<i>TPMT</i> polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemiaKarin Dreisig, Emilie Damgaard Brünner, Hanne V Marquart, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2021
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyStine Nygaard Nielsen, Linea Natalie Toksvang, Kathrine Grell, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|June 11, 2020
Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemiaRikke Hebo Larsen, Lisa Lyngsie Hjalgrim, Kathrine Grell, et al.
The Lancet. Oncology|March 5, 2017
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trialStine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, et al.
Journal of Crohn'S & Colitis|June 20, 2018
Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel DiseaseAnne Grosen, Jacob Nersting, Mona Bungum, et al.
Pediatric Blood & Cancer|July 23, 2016
Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?Kjeld Schmiegelow, Jacob Nersting, Stine Nygaard Nielsen, et al.
BMC Health Services Research|December 5, 2020
Interprofessional versus monoprofessional case-based learning in childhood cancer and the effect on healthcare professionals' knowledge and attitudes: study protocol for a randomised trialMartha Krogh Topperzer, Marianne Hoffmann, Hanne Bækgaard Larsen, et al.
Pediatric Blood & Cancer|May 10, 2018
Testing physical function in children undergoing intense cancer treatment-a RESPECT feasibility studyMartin K F Nielsen, Jesper F Christensen, Thomas L Frandsen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Blood|February 20, 2009
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 studyKjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, et al.
Pediatric Hematology and Oncology|November 18, 2020
<i>TPMT</i> polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemiaKarin Dreisig, Emilie Damgaard Brünner, Hanne V Marquart, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2021
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyStine Nygaard Nielsen, Linea Natalie Toksvang, Kathrine Grell, et al.
Pageof 5